FDA Pharmaceutical Approval Process. The process of drug discovery and resulting
time to market ranges between 12-20 years and typically ...

http://www.mannfbe.org/commercialize/timeline.htm

... Report, (part of the Standard Development Process) to help determine the potential
clinical adoption of an emerging medical technology or pharmaceutical. ...

http://www.mannfbe.org/commercialize/clinical_assessment.htm

... expensive process that includes several phases, including drug discovery and drug
development, with the vast majority of candidate pharmaceutical compounds not ...

http://www.mannfbe.org/biomedtech/pharmaceuticals.htm

Competitive Analysis provides a comprehensive assessment of the competitive
landscape for an emerging medical technology or pharmaceutical. ...

http://www.mannfbe.org/commercialize/competitive_analysis.htm

... The specific point of exit for a particular biomedical or pharmaceutical technology
is determined on a project by project basis and may be executed at ...

http://www.mannfbe.org/foundations/development-focus.htm

... Pharmaceutical, device and diagnostic companies are attempting to capture part
of this revenue through innovative private pay programs. ...

http://www.mannfbe.org/commercialize/reimbursement.htm

... Pharmaceutical clinical testing consists of several phases, with increasing
numbers of human subjects tested during each phase. ...

http://www.mannfbe.org/commercialize/regulatory.htm

Alfred Mann Institutes follow a Standard Development Process to ensure that each
step tracks best practices in medical device and pharmaceutical development. ...

http://www.mannfbe.org/commercialize/standard.htm

... to experienced industry representatives such as CEOs or senior executives of well
established medical device, biotechnology and pharmaceutical companies. ...

http://www.mannfbe.org/foundations/governance.htm

... The Institute is staffed with individuals with pertinent industry experience in
medical device, pharmaceutical and biologic commercialization. ...

http://www.mannfbe.org/foundations/institutes.htm

... The Institute dedicated to the creation of medical device and pharmaceutical products
and processes to improve human health and well-being will also have the ...

http://www.mannfbe.org/newsroom/pr_101206.htm

... Because of the small size of many of these companies, a number of them have partnered
with pharmaceutical firms or other biotechnology companies to leverage ...

http://www.mannfbe.org/biomedtech/biotechnology.htm

... NeuroSystec NeuroSyestec is a developer of device and pharmaceutical
technologies formulated to treat diseases of the nervous system. ...

http://www.mannfbe.org/mann/companies.htm

... into development pipelines, in companies ranging from local start-ups to large
multinational corporations within the pharmaceutical, biotechnology and medical ...

http://www.mannfbe.org/newsroom/pr_040108.htm

... referred to as combination products. Medical Device. Pharmaceutical.
Biotechnology. Combination Device. The Alfred E Mann Foundation ...

http://www.mannfbe.org/biomedtech/

... can take from 4 to over 15 years from concept to commercialization, depending on
the complexity of the medical device, biologic or pharmaceutical and can cost ...

http://www.mannfbe.org/about/commercialization.htm

Presenting Your Idea. Inventors have a range of business opportunities and
obligations to present the concept of their technology. ...

http://www.mannfbe.org/commercialize/presenting.htm

Proof of Concept. Concepts for biomedical technologies and pharmaceuticals
evolve from ideas for commercialized products often based ...

http://www.mannfbe.org/commercialize/proof_of_concept.htm

... Although the AMIs are broadly focused on the development of biomedical technologies,
selected pharmaceutical or biologic projects may also be considered for ...

http://www.mannfbe.org/faqs/

FDA Medical Device Approval Process. The development of a medical device
from concept to product launch typically takes between 4 ...

http://www.mannfbe.org/commercialize/approval-process.htm